Edward Kim
Chief Tech/Sci/R&D Officer bei OREXO AB
Profil
Edward Kim is currently the Chief Medical Officer at Orexo AB since 2022.
Prior to this, he worked as the Vice Chairman-Clinical Services at Robert Wood Johnson Medical School and as the Vice President & Head-Medical Affairs at Biohaven Pharmaceutical Holding Co. Ltd.
Dr. Kim completed his undergraduate degree at Harvard University and his doctorate at Sidney Kimmel Medical College.
Aktive Positionen von Edward Kim
Unternehmen | Position | Beginn |
---|---|---|
OREXO AB | Chief Tech/Sci/R&D Officer | 26.10.2022 |
Ehemalige bekannte Positionen von Edward Kim
Unternehmen | Position | Ende |
---|---|---|
Robert Wood Johnson Medical School | Corporate Officer/Principal | - |
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Corporate Officer/Principal | - |
Ausbildung von Edward Kim
Harvard University | Undergraduate Degree |
Sidney Kimmel Medical College | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
OREXO AB | Health Technology |
Private Unternehmen | 1 |
---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |